AwardedUnited KingdomServices£310,000
Provision of SCID Screening Assay Kits
- Published
- Published 29 July 2025
- Deadline
- Closed 31 March 2025
Overview
A call off under National Microbiology Framework for the EONIS Q Assay methodology as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot (NBS) in-service evaluation for Severe Combined Immuno-Deficiency (SCID) in Screening laboratories to Revvity.
Key details
- Country
- United Kingdom
- Status
- Awarded
- Category
- Services
- Estimated value
- £310,000
- Procedure
- Selective
- SME suitable
- Yes
- Published
- 29 July 2025
- Deadline
- Closed
Health services
Award outcome
- Awarded value
- £310,000
- Award date
- 13 July 2025
- Contract period
- 31 March 2025 → 30 September 2025
- Revvity (UK) Limited
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
29 July 2025
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.